Inhibrx, Inc. Common Stock
INBX
INBX was delisted on the 29th of May, 2024.
51 hedge funds and large institutions have $513M invested in Inhibrx, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
107% more capital invested
Capital invested by funds: $248M → $513M (+$266M)
59% more funds holding
Funds holding: 32 → 51 (+19)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$28.1M |
| 2 |
BlackRock
New York
|
+$10.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.34M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$5.19M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$5.61M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$5.13M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.92M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$3.6M |
| 5 |
Goldman Sachs
New York
|
-$2.05M |
INBX Hedge Fund Activity: Q4 2020 in Review
51 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q4 2020, worth a combined $513M — up 107% from $248M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new INBX positions and 10 closed out — a net gain of 19 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $28.1M. The largest seller was Logos Global Management, exiting entirely with an estimated $5.61M sold.
- 51 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q4 2020, up from 32 in Q3 2020.
- Funds reported $513M of Inhibrx, Inc. Common Stock stock for Q4 2020, up 107% quarter-over-quarter.
- 29 funds opened new Inhibrx, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +19 holders.
- The largest Inhibrx, Inc. Common Stock buyer in Q4 2020 was ArrowMark Colorado Holdings, an estimated $28.1M added.
- The largest Inhibrx, Inc. Common Stock seller in Q4 2020 was Logos Global Management, an estimated $5.61M sold.
Based on aggregated 13F filings for Q4 2020.